Current methods for attaching targeting ligands to liposomes and nanoparticles

被引:256
|
作者
Nobs, L
Buchegger, F
Gurny, R
Allémann, E
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Univ Hosp Geneva, Nucl Med Serv, CH-1211 Geneva 14, Switzerland
关键词
nanoparticle; liposome; active targeting; surface modification; antibody; drug targeting; carrier system; immunoliposome;
D O I
10.1002/jps.20098
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Liposomes and nanoparticles have emerged as versatile carrier systems for delivering active molecules in the organism. These colloidal particles have demonstrated enhanced efficacy compared to conventional drugs. However, the design of liposomes and nanoparticles with a prolonged circulation time and ability to deliver active compounds specifically to target sites remains an ongoing research goal. One interesting way to achieve active targeting is to attach ligands, such as monoclonal antibodies or peptides, to the carrier. These surface-bound ligands recognize and bind specifically to target cells. To this end, various techniques have been described, including covalent and noncovalent approaches. Both in vitro and in vivo studies have proved the efficacy of the concept of active targeting. The present review summarizes the most common coupling techniques developed for binding homing moieties to the surface of liposomes and nanoparticles. Various coupling methods, covalent and noncovalent, will be reviewed, with emphasis on the major differences between the coupling reactions, on their advantages and drawbacks, on the coupling efficiency obtained, and on the importance of combining active targeting with long-circulating particles. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:1980 / 1992
页数:13
相关论文
共 50 条
  • [21] Liposomes for cardiovascular targeting
    Levchenko, Tatyana S.
    Hartner, William C.
    Torchilin, Vladimir P.
    THERAPEUTIC DELIVERY, 2012, 3 (04) : 501 - 514
  • [22] Liposomes in Drug Targeting
    Mukul, Kumar Basu
    Biotechnology and Genetic Engineering Reviews, 1994, (12)
  • [23] Pharmacokinetics of targeting with liposomes
    Harashima, H
    Ishida, T
    Kamiya, H
    Kiwada, H
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (03): : 235 - 275
  • [24] DRUGS TARGETING BY LIPOSOMES
    TORCHILIN, VP
    SMIRNOV, VN
    UKRAINSKII BIOKHIMICHESKII ZHURNAL, 1984, 56 (03): : 339 - 345
  • [25] Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
    Cheng, Zhe
    Huang, Huichao
    Yin, Meilong
    Liu, Huaizheng
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [26] Current status of development to improve the efficiency and targeting specificity of liposomes for gene therapy
    Hui, KM
    Gao, H
    FRONTIERS IN HUMAN GENETICS: DISEASES AND TECHNOLOGIES, 2001, : 301 - 322
  • [27] Targeting of Human B Lymphoma with Cytotoxic Liposomes Containing Glycan Ligands of CD22
    Chen, Weihsu Claire
    Completo, Gladys C.
    Paulson, James C.
    GLYCOBIOLOGY, 2008, 18 (11) : 963 - 963
  • [28] Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes
    Qu, Boyi
    Li, Xiaocen
    Guan, Mei
    Li, Xun
    Hai, Li
    Wu, Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 72 : 110 - 118
  • [29] A photo-triggered conjugation approach for attaching RGD ligands to biodegradable mesoporous silica nanoparticles for the tumor fluorescent imaging
    Xu, Xinyi
    Li, Hanrui
    Li, Ke
    Zeng, Qi
    Liu, Yin
    Zeng, Yun
    Chen, Dan
    Liang, Jimin
    Chen, Xueli
    Zhan, Yonghua
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 19 : 136 - 144
  • [30] Attaching DNA to Gold Nanoparticles With a Protein Corona
    Wu, Rong
    Peng, Huaping
    Zhu, Jun-Jie
    Jiang, Li-Ping
    Liu, Juewen
    FRONTIERS IN CHEMISTRY, 2020, 8